Serum Magnesium and Fractional Exhaled Nitric Oxide in Relation to the Severity in Asthma-Chronic Obstructive Pulmonary Disease Overlap

被引:8
|
作者
Ye, Mingzhi [1 ]
Li, Qianhong [1 ]
Xiao, Ling [1 ]
Zheng, Zhongsheng [1 ]
机构
[1] Shantou Univ, Coll Med, Dept Resp, Affiliated Hosp 1, 57 Changping Rd, Shantou City 515041, Guangdong, Peoples R China
关键词
Magnesium; Manganese; FEV1; FENO; ACO; MANGANESE; THERAPY; COPD;
D O I
10.1007/s12011-020-02314-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serum concentrations of magnesium and manganese may be associated with increased chronic obstructive pulmonary disease exacerbation risk. However, associations with other aspects of asthma-chronic obstructive pulmonary disease overlap, pulmonary function test results and health status, have been studied less extensively. The aim of this study was to investigate the associations between serum concentrations of trace elements and T lymphocyte subsets, FeNO, and COPD-related questionnaire scores in individuals with ACO and the potential impact of these parameters on lung function. All the patients met the diagnostic criteria of ACO and were divided into two groups (group A, mild-moderate; group B, severe-very severe) by their specific characteristics. Pulmonary function testing and serum Mg and serum Mn and FeNO were measured. Four hundred sixty-five patients were screened, and 42 were included. Group A had significantly higher Mg and Fe concentrations than group B. No significant differences were seen in the serum concentration of any other trace element between the two groups. Serum Mg and Mn were correlated with FEV1% predicted (p < 0.01). Group A had a significantly higher FeNO concentration than group B (p = 0.005). The scores on CAT (p = 0.011) and mMRC (p = 0.008) in group A were lower than in group B. The low-FeNO group had a significantly lower concentration of serum Mg than the high-FeNO group (p = 0.03). Pulmonary function declined faster (p < 0.05) in the low-FeNO group than the high-FeNO group. Serum Mg concentration may indicate protective effects against lung function loss in ACO. This implies that FeNO might be a biomarker for identifying individuals with ACO who might benefit from inhaled corticosteroid therapy. Serum Mg and FeNO were associated with ACO severity. However, their role in guiding personalised treatment of individuals with ACO needs to be further investigated.
引用
收藏
页码:1771 / 1777
页数:7
相关论文
共 50 条
  • [1] Serum Magnesium and Fractional Exhaled Nitric Oxide in Relation to the Severity in Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Mingzhi Ye
    Qianhong Li
    Ling Xiao
    Zhongsheng Zheng
    Biological Trace Element Research, 2021, 199 : 1771 - 1777
  • [2] Fractional Exhaled Nitric Oxide Testing: Diagnostic Utility in Asthma, Chronic Obstructive Pulmonary Disease, or Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome
    Miskoff, Jeffrey A.
    Dewan, Asa
    Chaudhri, Moiuz
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (06)
  • [3] Assessment of the role of fractional exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap
    Shebl, Eman
    Moety, Hanaa A.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2020, 69 (04): : 620 - 626
  • [4] Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome
    Guo, Yuanyuan
    Hong, Chunlin
    Liu, Yanhong
    Chen, Huinuan
    Huang, Xiaohua
    Hong, Minli
    MEDICINE, 2018, 97 (23)
  • [5] Comparison of Fractional Exhaled Nitric Oxide in Elderly Patients with Asthma-chronic Obstructive Pulmonary Disease Overlap and Other Airway Inflammatory Diseases
    Shi, Fei
    Qiu, Chen
    Yu, Jie
    Yang, Ying
    Li, Binbin
    Feng, Mengjie
    Zhang, Ting
    Liu, Wenwen
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2018, 17 (03) : 232 - 239
  • [6] The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome
    邓玎玎
    ChinaMedicalAbstracts(InternalMedicine), 2017, 34 (02) : 103 - 103
  • [7] Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Sharma, Sunita
    Khurana, Sandhya
    Federman, Alex D.
    Wisnivesky, Juan
    Holguin, Fernando
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2020, 40 (04) : 565 - 573
  • [8] Defining Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Godbout, Krystelle
    Gibson, Peter G.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (03) : 507 - 519
  • [9] Phenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Adrish, Muhammad
    Anand, Mahesh P.
    Hanania, Nicola A.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (03) : 645 - 655
  • [10] Imaging in Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Svenningsen, Sarah
    Kirby, Miranda
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (03) : 601 - 614